Talking therapy tested to ease fear after cancer immunotherapy ends
NCT ID NCT04761328
First seen Jan 04, 2026 · Last updated Jun 23, 2026 · Updated 33 times
Summary
This study tests whether cognitive behavioral therapy (CBT) can reduce fear, anxiety, and depression in cancer patients who are distressed about stopping immunotherapy. One hundred adults who have finished immunotherapy will receive CBT sessions. The goal is to see if this talking therapy improves quality of life and emotional well-being.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE BEHAVIORAL THERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UPMC Hillman Cancer Centers
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cognitive behavioral therapy
What this could lead to
If it works, this could offer a way to ease emotional distress and improve quality of life for cancer patients finishing immunotherapy.
What could go wrong
This is a small, early-stage study with no control group, so results may not be conclusive. The therapy may not work for everyone.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.